Clinical Observation of Fluoxetine in the Treatment of Post-stroke Depression
Zhang Chen
Abstract
Zhang Chen
Abstract
Objective To observe the clinical effect of fluoxetine in the treatment of post-stroke depression.Methods 64 patients with post-stroke depression were randomly divided into treatment group(fluoxetine treatment,n=32) and control group(conventional treatment,n=32).The curative effect was evaluated by the Hamilton rating scale for depression(HAMD),The index of activity of daily living(Barthel Index,BI),and Scandinavian Stroke Score(SSS).Results In treatment group,the HAMD was 15.1±1.4 after treatment,which was lower than 20.6±3.8 before treatment(P0.01).The SSS was decreased and BI was increased,comparing with control group,they had statistically significant difference(P﹤0.01).However the HAMD in control group was not significant difference prior and post treatment(P﹥0.05).Conclusions The antidepressant-fluoxetine in the treatment of post-stroke depression not only has remarkable antidepressive effect but also can improve the neurofunctional restoration.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the clinical effect of fluoxetine in the treatment of post-stroke depression.Methods 64 patients with post-stroke depression were randomly divided into treatment group(fluoxetine treatment,n=32) and control group(conventional treatment,n=32).The curative effect was evaluated by the Hamilton rating scale for depression(HAMD),The index of activity of daily living(Barthel Index,BI),and Scandinavian Stroke Score(SSS).Results In treatment group,the HAMD was 15.1±1.4 after treatment,which was lower than 20.6±3.8 before treatment(P0.01).The SSS was decreased and BI was increased,comparing with control group,they had statistically significant difference(P﹤0.01).However the HAMD in control group was not significant difference prior and post treatment(P﹥0.05).Conclusions The antidepressant-fluoxetine in the treatment of post-stroke depression not only has remarkable antidepressive effect but also can improve the neurofunctional restoration.
Key concepts: Hamd, Medicine, Fluoxetine, SSS*, Post-stroke depression, Depression (economics), Antidepressant, Barthel index